The Prime
Minister of Ireland -- the Taoiseach, Bertie Ahern -- today officially
dedicated the state-of-the-art Whitfield Clinic in Waterford, a major new
facility that incorporates the country's first cancer center to offer
advanced image-guided radiotherapy (IGRT) treatments.
The UPMC Whitfield Cancer Centre houses a Varian Clinac(R) linear
accelerator equipped with the country's first On-Board Imager(R), enabling
advanced image-guided treatments which better target the tumor and protect
healthy surrounding tissue. A second linear accelerator will be installed
next month.
The cancer center addresses the great need for radiotherapy services in
the southeast region of Ireland. Prior to its arrival, cancer patients in
the region were faced with more than two hours travelling time to the
nearest radiotherapy centers in Dublin or Cork.
Dr. Dayle Hacking, chief radiation oncologist at the Whitfield Cancer
Centre, said, "This splendid new facility will make a huge difference to
cancer patients in the southeast of Ireland. This region has been crying
out for its own dedicated radiotherapy resource and we now have something
that is both local and offers state-of-the-art advanced treatments to
improve cancer care."
The UPMC Whitfield Cancer Centre will also offer intensity-modulated
radiotherapy (IMRT) using the Varian equipment and software. IMRT enables
clinicians to improve the effectiveness of treatment and minimize
complications by matching the shape of the radiotherapy beams to the shape
of the tumor. The modern center will also enhance patient care by using new
software from Varian for planning sophisticated treatments, keeping
electronic medical records, processing images and managing clinical
processes and operations.
David Scott, Varian's UK & Ireland Sales Manager, adds, "This is a
wonderful new resource for cancer patients in the Southeast Ireland and
Varian is delighted to have been selected to equip the center with advanced
cancer treatment machines and software.
"More than half the Irish population has private health insurance and,
as the leading supplier to Irish private health centers as well as PPP
(public private partnership) projects in Ireland and the UK, Varian is
proud to be a part of this project."
Varian's On-Board Imager makes it possible for clinicians to image and
treat on a single machine that rotates around the patient to take X-ray
images and deliver treatments from virtually any angle. Mounted on the
medical linear accelerator, the On-Board Imager device produces
high-resolution images of the tumor and tracks changes in tumor shape, size
or position over a multi- week course of treatment. It also enables
clinicians to track and adjust for tumor motion caused by the patient's
breathing. Any adjustments to the patient's position can be carried out by
a radiation therapist entirely from outside the treatment room, allowing
for fast, automated image-guided radiotherapy.
Prior to the advent of image-guided radiotherapy (IGRT), radiation
oncologists had to contend with variations in patient positioning and with
respiratory motion by treating a relatively large margin of healthy tissue
around the tumor. IGRT enables doctors to minimize the volume of healthy
tissue exposed to the treatment beam. Potentially, image data from IGRT
tools like the On-Board Imager device will be used to note changes in tumor
size and shape over a course of treatment, and make real-time adaptations
to the treatment plan.
There are more than 5,800 radiotherapy centers worldwide, and Varian
equips 60 percent of these with its integrated and automated radiotherapy
systems. The market and technology leader in image-guided radiotherapy,
Varian has installed more than 250 On-Board Imager systems to date around
the world.
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California is the world's
leading manufacturer of medical technology for treating cancer and other
medical conditions with radiotherapy, brachytherapy, and radiosurgery. The
company is also a premier supplier of X-ray tubes and digital image
detectors for imaging in medical, scientific, and industrial applications.
The company's high-energy imaging systems are also used for screening
cargo. Varian Medical Systems employs approximately 3,600 people who are
located at manufacturing sites in North America and Europe and in its 56
sales and support offices around the world. In Europe, the company operates
manufacturing and engineering centers in Baden (Switzerland), Crawley
(England), Haan (Germany), Helsinki (Finland) and Toulouse (France) and has
headquarters for Europe, Middle East, India and Africa (EMEA) based in Zug,
Switzerland. Additional information is available on the company's web site
at varian/.
Forward Looking Statements
Statements in this press release regarding future business, events,
plans, objectives, expectations, estimates, and other similar matters,
including, but not limited to, statements using the terms "can" and
"expect," constitute forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such forward-looking
statements contained in this press release are subject to risks and
uncertainties that could cause actual results to differ materially from
those anticipated, including, but not limited to, the risks described in
the Company's Annual Report on Form 10-K and other reports filed from time
to time by the Company with the U.S. Securities and Exchange Commission.
These forward-looking statements represent the Company's judgment as of the
date of this press release. The Company assumes no obligation to update or
revise these forward-looking statements because of new information, future
events, or otherwise. Furthermore, notwithstanding any specific events
announced in this press release, the Company's quarterly and annual
financial results are subject to such risks and uncertainties described in
the Company's Annual Report on Form 10-K and other reports filed from time
to time by the Company with the U.S. Securities and Exchange Commission and
actual results may differ materially from those anticipated.
Varian Medical Systems, Inc
varian/